According to WHO, it can be difficult to clinically distinguish Ebola disease from other infectious diseases such as malaria, ...

India’s scientific excellence provides us the opportunity to achieve self-reliance in pharmaceuticals, biopharma and holistic ...

Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...

Combination rapid antigen tests (RATs), which allow users to test for influenza A and B as well as COVID-19, have recently ...

Dr Rajeev Jayadevan explains why a vaccine created for one Ebola strain may not necessarily protect against another and why ...

Perth biotechs Avicena Systems and Syngenis Laboratories are fast-tracking pathogen detection technology to protect Australia’s health, trade and agriculture.

Bundibugyo ebolavirus (BDBV) has a fatality rate of up to 40%. A small number of experimental vaccines and therapies are ...

An Irish company has launched a new hantavirus antibody detection kit, and it is already getting inquiries from around the ...

Last May 17, 2026, the World Health Organization Director General Tedros Ghebreyesus declared the ongoing epidemic of the Bundibugyo strain of the Ebola ...

How Big Pharma, Bioweapons, and the Globalist Depopulation Agenda Manufactured the Myth of Contagious Disease” exposes the ...

Within a couple of days, the Nebraska Public Health Laboratory developed — and validated — what's believed to be the only diagnostic test for the Andes hantavirus in the U.S.

Ebola is spreading faster than responders can track it in eastern Congo, where health workers managed to follow up with barely one in five identified contacts in a single day.